Is Rapport Therapeutics a good buy right now?
USNASDAQ: RAPPNASDAQ-listedlast $34.89 · 25 Sep 2026
Not yet — wait
Signal paused. RAPP's price history has a jump — most likely a split or bonus issue that was not adjusted — and 2 trades touching it were left out until the data is checked. The last Buy signal came on 1 Sep 2026 at $48.89 and closed on 9 Sep 2026 (−11.6%).
As of 30 Sep 2026 · Firefly Breakout Weekly
What happened after the last 8 buy signals on RAPP
Oct 2024 – 30 Sep 20261 of 8 closed above the entry price, with an average outcome of −9.9% per signal before costs; a signal typically stayed open about 6 d. 2 trades touching a jump in the price data were left out.
| Buy signal | Price then | Closed | Held | Outcome |
|---|---|---|---|---|
| 1 Sep 2026 | $48.89 | 9 Sep 2026 | 8 d | -11.6% |
| 8 May 2026 | $40.61 | 13 May 2026 | 5 d | -10.0% |
| 7 May 2026 | $40.6 | 7 May 2026 | 1 d | -10.0% |
| 16 Apr 2026 | $39.55 | 27 Apr 2026 | 11 d | -11.2% |
| 10 Sep 2025 | $23.91 | 5 Feb 2026 | 5 mo | +5.4% |
| 10 Jul 2025 | $15.55 | 15 Jul 2025 | 5 d | -12.0% |
| 7 Nov 2024 | $27.05 | 13 Nov 2024 | 6 d | -19.3% |
| 6 Nov 2024 | $26.76 | 6 Nov 2024 | 1 d | -10.4% |
Outcomes are simulated by applying Firefly's rules to historical prices, before costs and slippage. Sell triggers are not counted: Firefly reads them as “don't enter”, not as short trades. Past behaviour of a rule is not a prediction of future prices.
The strategy behind this page
one rule set per market · beta| Strategy | Horizon | Signal | Since | Buy signals closed higher |
|---|---|---|---|---|
| Firefly Breakout Weekly | Medium term | No signal | — | 13% |
This beta publishes one rule set per market — Firefly Breakout Weekly — chosen in the October 2026 review. What the beta shows and how the data was cleaned →
Same theme beyond US
same theme, other marketsIndian peers are listed on the NSE and priced in rupees. Crypto gains are taxed at 30% in India with 1% TDS. Shown for context — not a recommendation to switch markets.
More questions about RAPP
RAPP share price today — buy or sell?
As of 30 Sep 2026, Firefly Breakout Weekly says wait on Rapport Therapeutics. Signal paused. RAPP's price history has a jump — most likely a split or bonus issue that was not adjusted — and 2 trades touching it were left out until the data is checked. The last Buy signal came on 1 Sep 2026 at $48.89 and closed on 9 Sep 2026 (−11.6%). The last price on record was $34.89 on 25 Sep 2026.
How has Firefly's strategy done on Rapport Therapeutics?
From October 2024 to 30 Sep 2026 Firefly's rules gave 8 buy signals on Rapport Therapeutics; 1 closed above the entry price and the average outcome was −9.9% per signal, simulated on historical prices before costs. A handful of signals is a pattern, not a statistic.
What is the Rapport Therapeutics price target?
We don't publish price targets — no rule-based system can forecast a price. Firefly Breakout Weekly closes each signal by its own rules; every closed signal on Rapport Therapeutics and how it turned out is listed on this page.
Should I sell Rapport Therapeutics?
No sell trigger is active on Rapport Therapeutics as of 30 Sep 2026. This describes a rule, not advice on your position.
Why does this page show a single strategy?
This is the Signals beta. Each market publishes one rule set — here Firefly Breakout Weekly — instead of a vote across Firefly's whole library, and the verdict is its signal as of 30 Sep 2026. Sell triggers count as “don't enter”; only buy triggers are scored.
Fintrens shows how one of Firefly's rule-based strategies reads this stock. It is educational information, not investment advice and not a recommendation to buy or sell. We do not publish price targets. Indian residents buy US stocks under the RBI's Liberalised Remittance Scheme; tax is collected at source above the annual threshold. Read how Firefly's strategies work →